Vanguard discloses 0 shares ownership in Cohen & Steers (NYSE: CNS)
Rhea-AI Filing Summary
The Vanguard Group filed Amendment No. 6 to a Schedule 13G/A reporting its beneficial ownership in Cohen & Steers Inc. The filing states amount beneficially owned: 0 shares, representing 0% of the common stock.
The amendment explains an internal realignment effective January 12, 2026 under SEC Release No. 34-39538 that led certain Vanguard subsidiaries or business divisions to report disaggregated ownership separately.
Positive
- None.
Negative
- None.
Insights
Amendment records zero beneficial ownership after Vanguard reorganization.
The filing lists 0 shares and 0% beneficial ownership in Cohen & Steers common stock. This reflects a reporting change tied to an internal realignment described as occurring on January 12, 2026, citing SEC Release No. 34-39538.
Cash‑flow treatment and any associated trading activity are not disclosed in the excerpt; subsequent filings from Vanguard or its subsidiaries would show whether any affiliated accounts report holdings.
Filing is procedural, documenting disaggregation of reporting units.
The amendment follows the SEC release allowing subsidiaries to report separately; it states that Vanguard no longer is deemed to beneficially own securities held by those units. The document explicitly ties the change to the January 12, 2026 realignment.
For investors, this is an administrative disclosure; material ownership by related entities would appear in their separate filings.
FAQ
What does the Schedule 13G/A amendment say about Vanguard's stake in CNS?
Why did The Vanguard Group change how it reports ownership in CNS?
Does the filing indicate Vanguard sold shares of Cohen & Steers?
Who signed the Schedule 13G/A amendment for Vanguard?